CD4 and inflammatory bowel disease: The dysregulation of Th17 cells is closely associated with muptiple diseases, such as psoriasis, inflammatory bowel disease (IBD), and cancers, making them therapeutic targets for regulating immune dysfunctions.247 Th17 and Treg cells both originate from CD4+ naive T cells.